Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Price Cap Agency Considers Drug Packaging Cost Pass-Along

This article was originally published in PharmAsia News

Executive Summary

India's drug-pricing agency is expected to allow the pharmaceutical industry to pass on the increasing cost of packaging the products. The industry had proposed the pass-along as rising packaging costs figured larger in the cost of marketing the medicines. As a result, the National Pharmaceutical Pricing Authority asked drug makers to submit their actual costs so it can revise the cap on the price that can be charged at the retail level. Makers also have argued that part of the increased packaging cost, particularly for innovative and specialized drugs, is due to a need for packaging techniques to guard against counterfeits. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070853

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel